# Bayesian Update: Post-Tier 2 Evidence

**Bank**: Barclays PLC
**Date**: 2025-12-20
**Prior P(ARCHITECT) (post-Tier 1)**: 95%

---

## Tier 2 Evidence Summary

| ID | Evidence | Direction | LR |
|----|----------|-----------|-----|
| BARC-003 | Lee Braine warning: "some business lines might die" without CDM (Nov 2019) | SUPPORTS_ARCHITECT | 2.5 |
| BARC-005 | Barclays paper: exchanges/CCPs should lead CDM infrastructure (Mar 2021) | SUPPORTS_ARCHITECT | 2.0 |
| BARC-006 | Continued advocacy: repo clearing could spur CDM adoption (Dec 2023) | SUPPORTS_ARCHITECT | 1.8 |

## Likelihood Ratio Calculation

**Combined LR (Tier 2)** = 2.5 × 2.0 × 1.8 = **9.0**

## Posterior Calculation

```
Prior odds (post-Tier 1) = 0.95 / 0.05 = 19.0
Posterior odds = 19.0 × 9.0 = 171.0
Posterior P(ARCHITECT) = 171.0 / (1 + 171.0) = 0.994 = 99.4%
```

## Updated Probability

| Metric | Value |
|--------|-------|
| **P(ARCHITECT)** | 99% |
| **P(PRAGMATIST)** | 1% |
| **Direction of Movement** | Slightly Increased (95% → 99%) |

## Key Insights

1. **Sustained Advocacy**: Lee Braine's commentary spans 2019-2023 showing sustained commitment to CDM adoption
2. **Strategic Positioning**: Barclays articulating vision for CDM infrastructure (exchanges/CCPs as operators)
3. **Recent Engagement**: Dec 2023 commentary shows continued active involvement post-EMIR Refit
4. **Business Case Development**: Messaging around cost savings ($3B industry potential) suggests economic analysis underlying advocacy

## Cumulative Evidence Assessment

| Tier | Combined LR | Cumulative LR |
|------|-------------|---------------|
| Tier 1 | 42.0 | 42.0 |
| Tier 2 | 9.0 | 378.0 |

**Net Effect**: Tier 2 advocacy evidence strongly reinforces Tier 1 technical evidence. Pattern shows strategic commitment + technical capability + thought leadership.

## Confidence Assessment

- **Tier 2 Evidence Quality**: High (trade press reporting on named executive statements, published white papers)
- **Applied Confidence**: 82% (abundant evidence across multiple sources and time periods)
- **Maximum Confidence (Tier 2 cap)**: 75% (per CLAUDE.md rules - Tier 2 max is 75%)

## Critical Note on Confidence Capping

Per CLAUDE.md Section 7, Tier 2-only evidence caps confidence at 75%. Despite P(ARCHITECT) reaching 99%, applied confidence is capped at **75%** due to:
- Lack of Tier 1 production deployment evidence (only prototypes/POCs confirmed)
- Classification as ARCHITECT-Follower vs ARCHITECT-Native requires higher tier evidence

---

*Proceeding to Tier 3 evidence gathering.*
